Tvardi Therapeutics Cash Flow Statement (2013-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-30.75M	-1.01M	-33.38M	-31.38M	-7.45M	-26.33M	-31.80M	-29.15M	-32.84M	-30.30M	-33.11M	-31.03M	-7.10M	-9.88M	-10.72M	-9.58M	-25.92M	-40.00M	-8.69M	-7.55M
Share-based Compensation (Quarter)	0.06M	0.06M	8.78M	5.70M	0.10M	0.11M	3.80M	3.35M	0.12M	0.41M	3.60M	0.08M	0.08M	0.08M	0.08M	0.08M	0.63M	3.70M	0.35M	0.37M
Asset Writedowns and Impairment (Quarter)													1.49M	4.27M
Cash from Restructuring (Quarter)															0.44M	0.78M	-0.35M
Cash from Operations (Quarter)	-21.00M	-14.12M	-1.25M	-25.52M	-4.50M	-25.19M	-23.51M	-34.62M	-20.45M	-19.64M	-17.37M	-30.45M	23.64M	-6.66M	-4.83M	-7.69M	-5.87M	-4.24M	-5.70M	-5.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.19M	-0.21M	-0.27M	-0.29M	-0.24M	0.03M	0.23M	0.09M	-0.04M	0.10M	0.24M	0.51M	0.03M			0.07M	0.07M	0.03M	0.03M	0.04M
Amortization of Deferred Charges (Quarter)							0.37M	0.38M	0.38M	0.46M	0.85M	0.27M	0.26M	0.24M
Depreciation & Amortization (CF) (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.08M	0.04M	0.01M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M
Change in Working Capital
Change in Inventory (Quarter)				-0.68M	1.55M	-1.62M	0.55M	1.13M	-0.10M	-0.15M	-0.45M	-0.08M	0.39M	0.00M	0.73M
Change in Accured Expenses (Quarter)	-1.39M	0.32M	2.05M	0.64M	2.83M	6.98M	-4.78M	-6.32M	9.25M	-2.90M	3.24M	-10.15M	12.73M	-1.62M	4.61M	-2.64M	2.78M	0.79M		0.21M
Other Working Capital Changes (Quarter)	-0.39M	-0.41M	-0.42M	-0.42M	-0.43M	-0.45M	-0.46M	-0.46M	-0.47M	1.04M				-0.02M	-0.02M	-0.02M	-0.03M	-0.03M	-0.03M	-0.03M
Investing Activities
Capital Expenditures (Quarter)				0.04M							1.57M	0.84M	-0.82M	1.03M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)	1.00M	1.00M		44.00M			58.25M	29.50M	42.77M	46.33M	36.85M	59.00M	15.50M	2.50M	5.00M	5.49M	5.56M	5.35M	5.00M	4.98M
Cash from Investing Activities (Quarter)	20.53M	14.43M	-53.58M	33.43M	29.68M	21.18M	44.42M	17.71M	32.80M	23.16M	-30.20M	25.95M	15.29M	2.50M	5.00M	-10.88M	-9.55M	5.35M	5.00M	4.98M
Financing Activities
Other financing activities (Quarter)			0.32M	0.00M	0.18M	0.10M	0.02M	0.56M		-0.00M	0.00M					0.00M	0.42M	0.11M	0.00M
Debt Issuance and Repayment
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	6.00M	5.97M	6.51M	7.43M	7.42M	7.65M	0.64M	8.99M	8.13M	8.04M	0.66M	0.24M	6.07M	2.28M	0.73M	0.11M	1.22M	0.69M	1.21M	0.82M
Net Equity Issued and Repurchased (Quarter)										1.12M
Misc.
Cash from Financing Activities (Quarter)	0.29M	0.34M	45.29M	0.00M	0.18M	0.10M	0.02M	0.56M		1.12M	36.48M	-0.69M	0.69M	-0.01M	27.01M	-1.60M	24.63M	-0.32M	0.00M
Change in Cash (Quarter)	-0.18M	0.66M	-9.54M	7.91M	25.36M	-3.91M	20.93M	-16.35M	12.36M	4.63M	-11.10M	-5.19M	-1.62M	-6.67M	22.18M	-20.18M	9.21M	0.77M	-0.68M	-0.88M
Free Cash Flow (Quarter)	-21.00M	-14.12M	-1.25M	-25.57M	-4.50M	-25.19M	-23.51M	-34.62M	-20.45M	-19.64M	-18.94M	-31.29M	24.45M	-7.68M	-4.83M	-7.69M	-5.87M	-4.24M	-5.70M	-5.90M
Net Cash Flow (Quarter)	-0.18M	0.66M	-9.54M	7.91M	25.36M	-3.91M	20.93M	-16.35M	12.36M	4.63M	-11.10M	-5.19M	39.62M	-4.17M	27.18M	-20.18M	9.21M	0.78M	-0.70M	-0.92M

Research Tools

Datasets

Plans

Developers

Tvardi Therapeutics TVRD Cash Flow Statement (2013-2026)

Research Tools

Datasets

Plans

Developers

Tvardi Therapeutics TVRD Cash Flow Statement (2013-2026)

Create an account

Sign In

Reset Password